Importantly, five of these cytokines (IL-2RA, CCL5, CXCL1, MIF, and TRAIL), detailed above, that had changed values in CSF of MS patients independent of clinical presentation or laboratory findings. This evidence concerns the gene TNFSF10 and myeloid sarcoma.